Atea Pharmaceuticals, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-277815
- Form type
- 10-Q
- CIK
- 0001593899
- Primary document
- https://www.sec.gov/Archives/edgar/data/1593899/000119312525277815/avir-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Atea Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-126.0M | - | - |
| Net Income | $-113.5M | - | - |
| Eps Basic | -1.37 | - | - |
| Eps Diluted | -1.37 | - | - |
| Cash And Equivalents | $77.3M | - | - |
| Total Assets | $343.0M | - | - |
| Total Liabilities | $27.2M | - | - |
| Shareholders Equity | $315.8M | - | - |
| Operating Cash Flow | $-103.8M | - | - |